Diagnostic Challenge of Fungal Prosthetic Valve Endocarditis: A Case Report
Published: 2023-06-12
Page: 205-212
Issue: 2023 - Volume 6 [Issue 1]
Zainab Boudhar *
Cardiology Department, University Hospital of Marrakech, Morocco.
Hafssa Rouam
Cardiology Department, University Hospital of Marrakech, Morocco.
Saloua El Karimi
Cardiology Department, University Hospital of Marrakech, Morocco.
Mustapha El Hattaoui
Cardiology Department, University Hospital of Marrakech, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Fungal prosthetic valve endocarditis is an extremely severe form of infective endocarditis, with poor prognosis and high mortality rate of about 50%. To better characterize this syndrome, we present a case of fungal prosthetic valve endocarditis due to Candida albicans following aortic valve replacement.
Case Presentation: A 43-year-old male patient with history of aortic valve replacement, complicated with three thoracic empyema who have been drained, presented to emergency with high fever, cough, sputum and dyspnea. Transthoracic echocardiography evaluation demonstrated that the aortic prosthetic valve was dysfunctional and the leaflets were immobile with the existence of a very mobile and huge vegetation attached to this one measuring 22×12mm. the first blood cultures were all negative and the patient was treated initially for bacterial endocarditis with no noted clinical or biological improvement. Moreover, the patient presented several complications: left kidney infarction, impaired renal function and rhythmic complications, ventricular tachycardia (VT). On the 17th day of hospitalization, a fungal pathogen type Candida Albicans was isolated from a culture of the patient's blood. Fluconazole was given intravenously for about 2 weeks. Since fever continued, C-reactive protein (CRP) remained elevated and no reduction in the size of vegetation was observed, a surgical intervention was planned. The vegetation was removed and replacement of the aortic valve by a new mechanical prosthetic valve was performed. 24 hours after the surgery, patient died of a sepsis.
Conclusion: Fungal prosthetic valve endocarditis is rare, but fatal. The diagnosis and management are challenging. Any patient who fails to respond to antifungal agents should be referred to cardiac surgery. Some of these patients may require radical debridement and/or valve replacement. However, even with surgical treatment, survival rates are low.
Keywords: Aortic valve, dyspnea, echocardiography, fluconazole, cardiac surgery, heart failure, pulmonary, endocarditis
How to Cite
Downloads
References
Baddley JW, Benjamin DK Jr, Patel M, et al. International Collaboration on Endocarditis-Prospective Cohort Study Group (ICE-PCS). Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 2008;27:519–29.
Falcone M, Barzaghi N, Carosi G, et al. Italian study on endocarditis Candida infective endocarditis: Report of 15 cases from a prospective multicenter study. Medicine (Baltimore) 2009;88:160–8.
Badiee P, Amirghofran AA, Ghazi Nour M, Shafa M, Nemati MH. Incidence and outcome of documented fungal endocarditis. Int Cardiovasc Res J. 2014;8 (4):152–155.
Ellis M. Fungal endocarditis. J Infect. 1997;35(2):99-103.
Seelig MS, Speth CP, Kozinn PJ, Taschdjian CL, Toni EF, Goldberg P. Patterns of Candida endocarditis following cardiac surgery: Importance of early diagnosis and therapy (an analysis of 91 cases) Prog Cardiovasc Dis. 1974;17(2): 125–160.
Muehrcke DD. Fungal prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg. 1995;7:20–4.
Gordon SM, Keys TF. Bloodstream infections in patients with implanted prosthetic cardiac valves. Semin Thorac Cardiovasc Surg. 1995;7(1):2-6.
Simon MS, Somersan S, Singh HK, Hartman B, Wickes BL, Jenkins SG, et al. Endocarditis caused by rhodotorula infection. J Clin Microbiol. 2014;52(1):374–378.
Kami M, Fukui T, Ogawa S, Kazuyama Y, Machida U, Tanaka Y, et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis. 2001;33(9):1504-12.
Gordon SM, Keys TF. Bloodstream infections in patients with implanted prosthetic cardiac valves. Semin Thorac Cardiovasc Surg. 1995;7(1):2-6.
Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest. 2002;122 (1):302-10.
Klis FM. Review: Cell wall assembly in yeast. Yeast. 1994;10:851–869. DOI: 10.1002/yea.320100702
Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C., Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14 (6):R222.
Varghese GM, Sobel JD. Fungal endocarditis. Curr Infect Dis Rep. 2008;10 (4):275-9.
Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K, Heinen C, Crépin B, Van Eldere J, Tabouret M, Donnelly JP, Verweij PE. Optimization of the cutoff value for the aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis. 2007; 44(10):1329-36.
Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases. Rev Infect Dis. 1990;12(6):1147–1201.
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1-50.